DG 041
Alternative Names: D 151746; DG-041Latest Information Update: 13 Jan 2011
At a glance
- Originator deCODE genetics
- Class Small molecules; Sulfonamides; Thiophenes
- Mechanism of Action Dinoprostone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Suspended Peripheral arterial occlusive disorders
Most Recent Events
- 13 Jan 2011 Suspended - Phase-II for Peripheral arterial occlusive disorders in Europe (PO)
- 30 Jun 2008 DG 041 is available for licensing (http://www.decode.com)
- 30 Jun 2008 deCODE genetics completes a clinical pharmacology trial of DG 041 in combination with aspirin and clopidogrel